Trial
NCT05082584
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Akebia Therapeutics
Collaborators
—
Condition
Anemia of Chronic Kidney Disease
Intervention
Vadadustat
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-01